GlassScriptPhysician profile
Frieda Lewis
NPI 1588692909
$1,487.05
in general payments reported to CMS, 2019-2025
15 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $664 · 2021: $17.49 · 2022: $401 · 2023: $243 · 2024: $31.41 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.35 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $913.00 | 2019-2022 | |
| Astellas Pharma US INC | $153.74 | 2023-2025 | Veozah, Myrbetriq |
| Dysis Medical, INC. | $79.00 | 2022 | |
| Organon LLC | $59.33 | 2023-2025 | Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $52.38 | 2022-2025 | |
| Myriad Women'S Health, INC. | $52.00 | 2023 | Myrisk |
| Allergan, INC. | $51.40 | 2019 | |
| Abbvie INC. | $27.74 | 2023 | |
| Exeltis, USA INC. | $18.95 | 2025 | Slynd |
| Sage Therapeutics, LLC | $18.01 | 2025 | Zurzuvae |
| Millicent US INC | $17.64 | 2025 | Femlyv |
| Davol INC. | $17.49 | 2021 | |
| Channel Medsystems, INC. | $14.21 | 2023 | |
| Mayne Pharma Commercial LLC | $12.16 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frieda Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.